Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 323

  • The following terms were not found in PubMed: CA209923[Grant Number], CA232137[Grant Number], CA232161[Grant Number], CA232382[Grant Number].
1.

Computational algorithms for in silico profiling of activating mutations in cancer.

Jordan EJ, Patil K, Suresh K, Park JH, Mosse YP, Lemmon MA, Radhakrishnan R.

Cell Mol Life Sci. 2019 Apr 13. doi: 10.1007/s00018-019-03097-2. [Epub ahead of print] Review.

PMID:
30982079
2.

Shallow Sparsely-Connected Autoencoders for Gene Set Projection.

Gold MP, LeNail A, Fraenkel E.

Pac Symp Biocomput. 2019;24:374-385.

3.

In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens.

Chow RD, Wang G, Ye L, Codina A, Kim HR, Shen L, Dong MB, Errami Y, Chen S.

Nat Methods. 2019 Apr 8. doi: 10.1038/s41592-019-0371-5. [Epub ahead of print]

PMID:
30962622
4.

Tissue-specific oncogenic activity of K-RasA146T.

Poulin EJ, Bera AK, Lu J, Lin YJ, Strasser SD, Paulo JA, Huang TQ, Morales C, Yan W, Cook J, Nowak JA, Brubaker DK, Joughin BA, Johnson CW, DeStefanis RA, Ghazi PC, Gondi S, Wales TE, Iacob RE, Bogdanova L, Gierut JJ, Li Y, Engen JR, Perez-Mancera PA, Braun BS, Gygi SP, Lauffenburger DA, Westover KD, Haigis KM.

Cancer Discov. 2019 Apr 5. pii: CD-18-1220. doi: 10.1158/2159-8290.CD-18-1220. [Epub ahead of print]

PMID:
30952657
5.

SOX11 hypermethylation as a tumor biomarker in endometrial cancer.

Shan T, Uyar DS, Wang LS, Mutch DG, Huang TH, Rader JS, Sheng X, Huang YW.

Biochimie. 2019 Mar 29;162:8-14. doi: 10.1016/j.biochi.2019.03.019. [Epub ahead of print]

PMID:
30935961
6.

Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.

Schmainda KM, Prah MA, Hu LS, Quarles CC, Semmineh N, Rand SD, Connelly JM, Anderies B, Zhou Y, Liu Y, Logan B, Stokes A, Baird G, Boxerman JL.

AJNR Am J Neuroradiol. 2019 Apr;40(4):626-633. doi: 10.3174/ajnr.A6015. Epub 2019 Mar 28.

PMID:
30923088
7.

Stress-Induced Evolutionary Innovation: A Mechanism for the Origin of Cell Types.

Wagner GP, Erkenbrack EM, Love AC.

Bioessays. 2019 Apr;41(4):e1800188. doi: 10.1002/bies.201800188.

PMID:
30919472
8.

Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.

Kröger C, Afeyan A, Mraz J, Eaton EN, Reinhardt F, Khodor YL, Thiru P, Bierie B, Ye X, Burge CB, Weinberg RA.

Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7353-7362. doi: 10.1073/pnas.1812876116. Epub 2019 Mar 25.

9.

In situ 10-cell RNA sequencing in tissue and tumor biopsy samples.

Singh S, Wang L, Schaff DL, Sutcliffe MD, Koeppel AF, Kim J, Onengut-Gumuscu S, Park KS, Zong H, Janes KA.

Sci Rep. 2019 Mar 20;9(1):4836. doi: 10.1038/s41598-019-41235-9.

10.

The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies.

Gong J, Chehrazi-Raffle A, Placencio-Hickok V, Guan M, Hendifar A, Salgia R.

Clin Transl Med. 2019 Mar 18;8(1):9. doi: 10.1186/s40169-019-0225-x. Review.

11.

Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer.

Fritz AJ, Gillis NE, Gerrard DL, Rodriguez PD, Hong D, Rose JT, Ghule PN, Bolf EL, Gordon JA, Tye CE, Boyd JR, Tracy KM, Nickerson JA, van Wijnen AJ, Imbalzano AN, Heath JL, Frietze SE, Zaidi SK, Carr FE, Lian JB, Stein JL, Stein GS.

Genes Chromosomes Cancer. 2019 Mar 15. doi: 10.1002/gcc.22731. [Epub ahead of print] Review.

PMID:
30873710
12.

Computational KIR copy number discovery reveals interaction between inhibitory receptor burden and survival.

Pyke RM, Genolet R, Harari A, Coukos G, Gfeller D, Carter H.

Pac Symp Biocomput. 2019;24:148-159.

13.

A multi-targeted probe-based strategy to identify signaling vulnerabilities in cancers.

Rao S, Du G, Hafner M, Subramanian K, Sorger PK, Gray NS.

J Biol Chem. 2019 Mar 11. pii: jbc.RA118.006805. doi: 10.1074/jbc.RA118.006805. [Epub ahead of print]

14.

Modeling differentiation-state transitions linked to therapeutic escape in triple-negative breast cancer.

Chapman MP, Risom T, Aswani AJ, Langer EM, Sears RC, Tomlin CJ.

PLoS Comput Biol. 2019 Mar 11;15(3):e1006840. doi: 10.1371/journal.pcbi.1006840. eCollection 2019 Mar.

15.

Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme.

Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, Balagurunathan Y, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N.

Tomography. 2019 Mar;5(1):135-144. doi: 10.18383/j.tom.2018.00052.

16.

Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors.

Rapisuwon S, Izar B, Batenchuk C, Avila A, Mei S, Sorger P, Parks JM, Cooper SJ, Wagner D, Zeck JC, Charabaty AJ, Atkins MB.

J Immunother Cancer. 2019 Mar 4;7(1):61. doi: 10.1186/s40425-019-0533-0.

17.

Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.

Hu LS, Yoon H, Eschbacher JM, Baxter LC, Dueck AC, Nespodzany A, Smith KA, Nakaji P, Xu Y, Wang L, Karis JP, Hawkins-Daarud AJ, Singleton KW, Jackson PR, Anderies BJ, Bendok BR, Zimmerman RS, Quarles C, Porter-Umphrey AB, Mrugala MM, Sharma A, Hoxworth JM, Sattur MG, Sanai N, Koulemberis PE, Krishna C, Mitchell JR, Wu T, Tran NL, Swanson KR, Li J.

AJNR Am J Neuroradiol. 2019 Mar;40(3):418-425. doi: 10.3174/ajnr.A5981. Epub 2019 Feb 28.

PMID:
30819771
18.

Structure of the IFNγ receptor complex guides design of biased agonists.

Mendoza JL, Escalante NK, Jude KM, Sotolongo Bellon J, Su L, Horton TM, Tsutsumi N, Berardinelli SJ, Haltiwanger RS, Piehler J, Engleman EG, Garcia KC.

Nature. 2019 Mar;567(7746):56-60. doi: 10.1038/s41586-019-0988-7. Epub 2019 Feb 27.

PMID:
30814731
19.

Mismatch repair deficiency in high-grade meningioma: a rare but recurrent event associated with dramatic immune activation and clinical response to PD-1 blockade.

Dunn IF, Du Z, Touat M, Sisti MB, Wen PY, Umeton R, Dubuc AM, Ducar M, Canoll PD, Severson E, Elvin JA, Ramkissoon SH, Lin JR, Cabrera L, Acevedo B, Sorger PK, Ligon KL, Santagata S, Reardon DA.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00190. Epub 2018 Nov 27. No abstract available.

20.

Lesion Dynamics Under Varying Paracrine PDGF Signaling in Brain Tissue.

Massey SC, Hawkins-Daarud A, Gallaher J, Anderson ARA, Canoll P, Swanson KR.

Bull Math Biol. 2019 Feb 22. doi: 10.1007/s11538-019-00587-z. [Epub ahead of print]

PMID:
30796683

Supplemental Content

Loading ...
Support Center